Aspire-Lakewood Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire-Lakewood Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
Q2 2026 vs. Q1 2026
How the institutions holding Aspire-Lakewood Holdings, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 15 | 13 | −2 |
| Shares | 378.6K | 47.0K | −331.6K (−87.6%) |
| Value | $371.9K | $250.9K | −$121.1K (−32.6%) |
New holders (2)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 14,830 | $79.2K | 0.00% |
| Barclays PLC | 1 | $5 | 0.00% |
Sold out (4)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Morgan Stanley | 76,955 | $79.3K |
| Citigroup Inc | 1,846 | $1.90K |
| Advisor Group Holdings, Inc. | 2 | $2 |
| Caitong International Asset Management Co., Ltd | 1 | $1 |